Werner Verbiest, Johnson and Johnson Companion Diagnostics Center of Excellence

Werner Verbiest is Worldwide General Manager for Virco* (a research-based biotech company from the Janssen Group of Pharma-companies), and since 2010, also heads the Johnson and Johnson Companion Diagnostics Center of Excellence.**

Werner joined Virco in 1998 as Business & Development & Project Director and took on increasing responsibilities as Managing Director of Virco Central Virological Laboratory in Dublin – Ireland, and VP Virco Group. Werner has been actively involved in all phases of HIV clinical trial implementation and viral resistance test development, and has contributed numerous papers and presentations on antiretroviral resistance and viral pharmacogenomics.

Before joining Virco, he worked for 7 years at Janssen Research Foundation, where he was active in HIV Drug development and Hepatitis B therapeutic vaccine development.

*Virco is a research-driven biotechnology company whose mission is to enhance the clinical management of patients suffering from HIV-1 and other infectious diseases, and to improve their quality of life. Virco applies the latest technologies in molecular biology, bio-informatics and health information technology to develop advanced diagnostic tools that are based on the pharmacogenomics principles of individualized patient care.

** The Companion Diagnostics Center of Excellence is a cross-enterprise integrated capability and knowledge center to support discovery, development and sales & marketing of companion diagnostics for all therapeutic areas.